Related Experiment Video
Updated: May 1, 2026
17:16
Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 10, 2010
12.3K
Nanomedicine: An unresolved regulatory issue
1Innovative Therapeutics Group, Centre for Drug Administration, Health Sciences Authority, 11 Biopolis Way #11-03 Helios, Singapore 138667, Singapore. vivian. chan@nicnas.gov.au
Regulatory Toxicology and Pharmacology : RTP
|November 4, 2006
Summary
Nanomedicine leverages nanotechnology for molecular-scale health improvements, offering targeted drug delivery and enhanced therapies. However, comprehensive nanotoxicology studies are crucial to ensure safety for public health and the environment.
Area of Science:
- Nanomedicine
- Molecular scale health applications
- Nanotechnology in healthcare
Background:
- Nanomedicine utilizes nanotechnology for health maintenance and improvement at the molecular level.
- Applications include diagnostics, drug delivery, gene therapy, and tissue engineering.
- Nanomaterials offer advantages in drug concentration, therapeutic onset, and targeted delivery.
Purpose of the Study:
- To highlight the potential of nanomedicine in healthcare.
- To emphasize the need for rigorous assessment of health and environmental risks.
- To underscore the importance of nanotoxicology for safe application.
Main Methods:
- Review of current and potential nanomedicine applications.
- Analysis of the advantages of nanomaterials in medicine.
- Identification of knowledge gaps in risk assessment.
Main Results:
- Nanomedicine offers significant therapeutic advantages due to the unique properties of nanomaterials.
- There is a critical lack of research on the health and environmental risks associated with nanomedicine.
- Inhaled nanoparticles have been linked to lung injury, indicating potential toxicity.
Conclusions:
- Nanomedicine holds immense promise for revolutionizing healthcare.
- Urgent development of nanotoxicology is required to balance benefits against risks.
- Ensuring public health and environmental integrity is paramount for the responsible advancement of nanomedicine.
Related Concept Videos
01:17Drug Nomenclature
3.3K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
3.3K
01:25Drug Regulation
3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
706
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
706
01:28Drug Products: Biologics, Biosimilars and Interchangeables
369
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
369
01:29Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97